Axsome Therapeutics (AXSM) Net Margin (2022 - 2025)
Historic Net Margin for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 27.62%.
- Axsome Therapeutics' Net Margin rose 340400.0% to 27.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.89%, marking a year-over-year increase of 509800.0%. This contributed to the annual value of 74.47% for FY2024, which is 139400.0% up from last year.
- As of Q3 2025, Axsome Therapeutics' Net Margin stood at 27.62%, which was up 340400.0% from 31.95% recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' Net Margin peaked at 11.88% during Q1 2023, and registered a low of 469.82% during Q2 2022.
- In the last 4 years, Axsome Therapeutics' Net Margin had a median value of 91.09% in 2024 and averaged 128.84%.
- Per our database at Business Quant, Axsome Therapeutics' Net Margin surged by 3259900bps in 2023 and then tumbled by -792600bps in 2024.
- Axsome Therapeutics' Net Margin (Quarter) stood at 251.29% in 2022, then soared by 45bps to 137.89% in 2023, then surged by 54bps to 63.08% in 2024, then surged by 56bps to 27.62% in 2025.
- Its Net Margin was 27.62% in Q3 2025, compared to 31.95% in Q2 2025 and 48.91% in Q1 2025.